What metabolic disorder is characterized by an abnormal accumulation of homocysteine and its metabolites in blood and urine?

What metabolic disorder is characterized by an abnormal accumulation of homocysteine and its metabolites in blood and urine?

• A. Phenylketonuria
• B. Homocystinuria
• C. Cystinuria
• D. Argininemia

Answer: (B)

Homocystinuria is a metabolic disorder caused by a deficiency in the enzymes responsible for the metabolism of homocysteine, leading to its abnormal accumulation in the body. Specifically, it often stems from a deficiency in cystathionine beta-synthase, which is crucial for converting homocysteine to cystathionine. This accumulation of homocysteine and its metabolites can be detected in both blood and urine, and is associated with a variety of clinical symptoms such as developmental delays, cardiovascular issues, and skeletal abnormalities. The condition is linked to various genetic mutations that affect the body's ability to process homocysteine effectively. Early diagnosis and management are essential to prevent serious complications, highlighting the importance of understanding the biochemical pathways involved in this disorder. Phenylketonuria relates to the metabolism of phenylalanine rather than homocysteine. Cystinuria involves the defective transport of cysteine and some other amino acids, which does not lead to homocysteine accumulation. Argininemia is associated with the accumulation of arginine due to a defect in the enzyme arginase, and without any connection to homocysteine metabolism. Thus, the distinct biochemical pathway and clinical manifestations of homocystin

Homocystinuria is a metabolic disorder caused by a deficiency in the enzymes responsible for the metabolism of homocysteine, leading to its abnormal accumulation in the body. Specifically, it often stems from a deficiency in cystathionine beta-synthase, which is crucial for converting homocysteine to cystathionine. This accumulation of homocysteine and its metabolites can be detected in both blood and urine, and is associated with a variety of clinical symptoms such as developmental delays, cardiovascular issues, and skeletal abnormalities.

The condition is linked to various genetic mutations that affect the body's ability to process homocysteine effectively. Early diagnosis and management are essential to prevent serious complications, highlighting the importance of understanding the biochemical pathways involved in this disorder.

Phenylketonuria relates to the metabolism of phenylalanine rather than homocysteine. Cystinuria involves the defective transport of cysteine and some other amino acids, which does not lead to homocysteine accumulation. Argininemia is associated with the accumulation of arginine due to a defect in the enzyme arginase, and without any connection to homocysteine metabolism. Thus, the distinct biochemical pathway and clinical manifestations of homocystin